{"entity":{"type":"insider","cik":"0001659625","url":"/insider/0001659625","json_url":"/insider/0001659625.json","name":"Gosebruch Henry O","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":15,"first":"2017-08-02","last":"2023-09-19","span_basis":"filed_date"},"name_variants":[{"name":"Gosebruch Henry O","source":"filing","n_filings":15,"first_seen":"2017-08-02","last_seen":"2023-09-19"}],"transactions":[{"id":8237626,"accession":"0001610717-23-000290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-23-000290","line_url":"/filing/0001610717-23-000290#line-1","is_derivative":false,"issuer_cik":"0001659625","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001659625","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":12.6247,"price_display":"12.62","price_state":"stated","total_value":189370.5,"total_display":"189,370.50","total_whole":"189,371","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-19","scope":"insider"},{"id":8394018,"accession":"0001209191-23-028878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-028878","line_url":"/filing/0001209191-23-028878#line-1","is_derivative":false,"issuer_cik":"0001659625","issuer_name":"ACELYRIN, Inc.","issuer_ticker":"SLRN","issuer_name_source":null,"issuer_url":"/issuer/0001659625","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","total_whole":"900,000","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-11","scope":"insider"},{"id":9242728,"accession":"0001179110-22-003108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-003108","line_url":"/filing/0001179110-22-003108#line-1","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83960.0,"shares_display":"83,960","price_per_share":155.0,"price_display":"155.00","price_state":"stated","total_value":13013800.0,"total_display":"13,013,800.00","total_whole":"13,013,800","shares_owned_after":41623.0,"shares_owned_after_display":"41,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-20","scope":"insider"},{"id":6422397,"accession":"0001179110-22-003076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-22-003076","line_url":"/filing/0001179110-22-003076#line-2","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":83960.0,"shares_display":"83,960","price_per_share":155.0,"price_display":"155.00","price_state":"stated","total_value":13013800.0,"total_display":"13,013,800.00","total_whole":"13,013,800","shares_owned_after":16623.0,"shares_owned_after_display":"16,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":9242727,"accession":"0001179110-22-003107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-003107","line_url":"/filing/0001179110-22-003107","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":147.28754588,"price_display":"147.29","price_state":"stated","total_value":3682188.647,"total_display":"3,682,188.65","total_whole":"3,682,189","shares_owned_after":62767.0,"shares_owned_after_display":"62,767","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-05-20","scope":"insider","n_lines":4},{"id":6667457,"accession":"0001179110-22-001923","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-22-001923","line_url":"/filing/0001179110-22-001923","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":147.28754588,"price_display":"147.29","price_state":"stated","total_value":3682188.647,"total_display":"3,682,188.65","total_whole":"3,682,189","shares_owned_after":25890.0,"shares_owned_after_display":"25,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider","n_lines":4},{"id":6445709,"accession":"0001179110-22-001841","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-22-001841","line_url":"/filing/0001179110-22-001841","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":148.25572891333334,"price_display":"148.26","price_state":"stated","total_value":2223835.9337,"total_display":"2,223,835.93","total_whole":"2,223,836","shares_owned_after":42724.0,"shares_owned_after_display":"42,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-01","scope":"insider","n_lines":3},{"id":2114550,"accession":"0001179110-20-011342","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-011342","line_url":"/filing/0001179110-20-011342","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock, $0.01 par share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":99.37615,"price_display":"99.38","price_state":"stated","total_value":3975046.0,"total_display":"3,975,046.00","total_whole":"3,975,046","shares_owned_after":53106.0,"shares_owned_after_display":"53,106","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-20","filed_date":"2020-11-24","scope":"insider","n_lines":2},{"id":2202786,"accession":"0001567619-20-001013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-001013","line_url":"/filing/0001567619-20-001013#line-1","is_derivative":false,"issuer_cik":"0001659625","issuer_name":"Aptinyx Inc.","issuer_ticker":"APTX","issuer_name_source":null,"issuer_url":"/issuer/0001659625","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":125000.0,"shares_owned_after_display":"125,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-10","filed_date":"2020-01-14","scope":"insider"},{"id":8229744,"accession":"0001179110-19-008937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-008937","line_url":"/filing/0001179110-19-008937#line-1","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common Stock, $0.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":67.2795,"price_display":"67.28","price_state":"stated","total_value":2018385.0,"total_display":"2,018,385.00","total_whole":"2,018,385","shares_owned_after":75763.0,"shares_owned_after_display":"75,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2019-07-31","scope":"insider"},{"id":8237453,"accession":"0001104659-19-028074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-028074","line_url":"/filing/0001104659-19-028074#line-2","is_derivative":false,"issuer_cik":"0001659625","issuer_name":"Aptinyx Inc.","issuer_ticker":"APTX","issuer_name_source":null,"issuer_url":"/issuer/0001659625","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":96580.0,"shares_display":"96,580","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":372798.8,"total_display":"372,798.80","total_whole":"372,799","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-08","filed_date":"2019-05-09","scope":"insider"},{"id":8237448,"accession":"0001104659-19-028074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-028074","line_url":"/filing/0001104659-19-028074#line-1","is_derivative":false,"issuer_cik":"0001659625","issuer_name":"Aptinyx Inc.","issuer_ticker":"APTX","issuer_name_source":null,"issuer_url":"/issuer/0001659625","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3420.0,"shares_display":"3,420","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":12825.0,"total_display":"12,825.00","total_whole":"12,825","shares_owned_after":3420.0,"shares_owned_after_display":"3,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-07","filed_date":"2019-05-09","scope":"insider"},{"id":6513617,"accession":"0001179110-18-013337","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-013337","line_url":"/filing/0001179110-18-013337#line-1","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (EVP, Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42450.0,"shares_display":"42,450","price_per_share":90.1046,"price_display":"90.10","price_state":"stated","total_value":3824940.27,"total_display":"3,824,940.27","total_whole":"3,824,940","shares_owned_after":30350.0,"shares_owned_after_display":"30,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-11-30","scope":"insider"},{"id":5057576,"accession":"0001179110-17-013599","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-17-013599","line_url":"/filing/0001179110-17-013599","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18300.0,"shares_display":"18,300","price_per_share":90.54847536612021,"price_display":"90.55","price_state":"stated","total_value":1657037.0992,"total_display":"1,657,037.10","total_whole":"1,657,037","shares_owned_after":69719.0,"shares_owned_after_display":"69,719","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-30","filed_date":"2017-10-31","scope":"insider","n_lines":4},{"id":5029465,"accession":"0001179110-17-010983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-010983","line_url":"/filing/0001179110-17-010983","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, par value $0.01","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":70.42333333333333,"price_display":"70.42","price_state":"stated","total_value":21127.0,"total_display":"21,127.00","total_whole":"21,127","shares_owned_after":83637.0,"shares_owned_after_display":"83,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider","n_lines":2},{"id":4556989,"accession":"0001179110-17-010982","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-29","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5663.0,"shares_display":"5,663","price_per_share":70.0,"price_display":"70.00","price_state":"stated","total_value":396410.0,"total_display":"396,410.00","total_whole":"396,410","shares_owned_after":96074.0,"shares_owned_after_display":"96,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556988,"accession":"0001179110-17-010982","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-28","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1537.0,"shares_display":"1,537","price_per_share":70.01,"price_display":"70.01","price_state":"stated","total_value":107605.37,"total_display":"107,605.37","total_whole":"107,605","shares_owned_after":94437.0,"shares_owned_after_display":"94,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556987,"accession":"0001179110-17-010982","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-27","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":70.19,"price_display":"70.19","price_state":"stated","total_value":84228.0,"total_display":"84,228.00","total_whole":"84,228","shares_owned_after":86337.0,"shares_owned_after_display":"86,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556986,"accession":"0001179110-17-010982","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-26","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":70.11,"price_display":"70.11","price_state":"stated","total_value":70110.0,"total_display":"70,110.00","total_whole":"70,110","shares_owned_after":91437.0,"shares_owned_after_display":"91,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556985,"accession":"0001179110-17-010982","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-25","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":70.13,"price_display":"70.13","price_state":"stated","total_value":56104.0,"total_display":"56,104.00","total_whole":"56,104","shares_owned_after":89737.0,"shares_owned_after_display":"89,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556984,"accession":"0001179110-17-010982","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-24","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":70.21,"price_display":"70.21","price_state":"stated","total_value":49147.0,"total_display":"49,147.00","total_whole":"49,147","shares_owned_after":85137.0,"shares_owned_after_display":"85,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556983,"accession":"0001179110-17-010982","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-23","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":70.12,"price_display":"70.12","price_state":"stated","total_value":49084.0,"total_display":"49,084.00","total_whole":"49,084","shares_owned_after":90537.0,"shares_owned_after_display":"90,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556982,"accession":"0001179110-17-010982","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-22","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":70.23,"price_display":"70.23","price_state":"stated","total_value":42138.0,"total_display":"42,138.00","total_whole":"42,138","shares_owned_after":84137.0,"shares_owned_after_display":"84,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556981,"accession":"0001179110-17-010982","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-21","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":70.16,"price_display":"70.16","price_state":"stated","total_value":42096.0,"total_display":"42,096.00","total_whole":"42,096","shares_owned_after":88937.0,"shares_owned_after_display":"88,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556980,"accession":"0001179110-17-010982","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-20","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":70.02,"price_display":"70.02","price_state":"stated","total_value":42012.0,"total_display":"42,012.00","total_whole":"42,012","shares_owned_after":93837.0,"shares_owned_after_display":"93,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556979,"accession":"0001179110-17-010982","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-19","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":70.2,"price_display":"70.20","price_state":"stated","total_value":35100.0,"total_display":"35,100.00","total_whole":"35,100","shares_owned_after":85837.0,"shares_owned_after_display":"85,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556978,"accession":"0001179110-17-010982","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-18","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":70.18,"price_display":"70.18","price_state":"stated","total_value":35090.0,"total_display":"35,090.00","total_whole":"35,090","shares_owned_after":87837.0,"shares_owned_after_display":"87,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556977,"accession":"0001179110-17-010982","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-17","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":70.22,"price_display":"70.22","price_state":"stated","total_value":28088.0,"total_display":"28,088.00","total_whole":"28,088","shares_owned_after":84737.0,"shares_owned_after_display":"84,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556976,"accession":"0001179110-17-010982","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-16","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":70.17,"price_display":"70.17","price_state":"stated","total_value":28068.0,"total_display":"28,068.00","total_whole":"28,068","shares_owned_after":88537.0,"shares_owned_after_display":"88,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556975,"accession":"0001179110-17-010982","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-15","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":70.1,"price_display":"70.10","price_state":"stated","total_value":28040.0,"total_display":"28,040.00","total_whole":"28,040","shares_owned_after":92437.0,"shares_owned_after_display":"92,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556974,"accession":"0001179110-17-010982","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-14","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":70.07,"price_display":"70.07","price_state":"stated","total_value":28028.0,"total_display":"28,028.00","total_whole":"28,028","shares_owned_after":93037.0,"shares_owned_after_display":"93,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556973,"accession":"0001179110-17-010982","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-13","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":70.185,"price_display":"70.18","price_state":"stated","total_value":21055.5,"total_display":"21,055.50","total_whole":"21,056","shares_owned_after":87537.0,"shares_owned_after_display":"87,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556972,"accession":"0001179110-17-010982","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-12","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":70.04,"price_display":"70.04","price_state":"stated","total_value":21012.0,"total_display":"21,012.00","total_whole":"21,012","shares_owned_after":93537.0,"shares_owned_after_display":"93,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556971,"accession":"0001179110-17-010982","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-11","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":70.25,"price_display":"70.25","price_state":"stated","total_value":14050.0,"total_display":"14,050.00","total_whole":"14,050","shares_owned_after":83937.0,"shares_owned_after_display":"83,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556970,"accession":"0001179110-17-010982","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-10","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":70.175,"price_display":"70.18","price_state":"stated","total_value":14035.0,"total_display":"14,035.00","total_whole":"14,035","shares_owned_after":88337.0,"shares_owned_after_display":"88,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556969,"accession":"0001179110-17-010982","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-9","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":70.115,"price_display":"70.12","price_state":"stated","total_value":14023.0,"total_display":"14,023.00","total_whole":"14,023","shares_owned_after":91237.0,"shares_owned_after_display":"91,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"},{"id":4556968,"accession":"0001179110-17-010982","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-17-010982","line_url":"/filing/0001179110-17-010982#line-8","is_derivative":false,"issuer_cik":"0001551152","issuer_name":"AbbVie Inc.","issuer_ticker":"ABBV","issuer_name_source":null,"issuer_url":"/issuer/0001551152","owner_cik":"0001659625","owner_name":"Gosebruch Henry O","owner_display_name":"Gosebruch Henry O","owner_url":"/insider/0001659625","role":"Officer (Chief Strategy Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategy Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategy Officer","security_title":"Common stock, $0.01 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":70.34,"price_display":"70.34","price_state":"stated","total_value":7034.0,"total_display":"7,034.00","total_whole":"7,034","shares_owned_after":83737.0,"shares_owned_after_display":"83,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-31","filed_date":"2017-08-02","scope":"insider"}],"collapsed":true,"next_cursor":"2017-07-31|4556968","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":51,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001885522","name":"Neumora Therapeutics, Inc.","url":"/issuer/0001885522","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2023-09-19","last_seen":"2023-09-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001962918","name":"ACELYRIN, Inc.","url":"/issuer/0001962918","role":"Director","n_filings":1,"first_seen":"2023-05-11","last_seen":"2023-05-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001551152","name":"AbbVie Inc.","url":"/issuer/0001551152","role":"Officer (EVP, Chief Strategy Officer)","n_filings":11,"first_seen":"2017-08-02","last_seen":"2022-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001674365","name":"Aptinyx Inc.","url":"/issuer/0001674365","role":"Director","n_filings":2,"first_seen":"2019-05-09","last_seen":"2020-01-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001659625","retrieved_at":"2026-08-26T06:01:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}